Clinical outcome in patients receiving systemic therapy for metastatic sarcomatoid renal cell carcinoma: A retrospective analysis☆Sumanta K. Pal, Clayton Lau, Robert A. Figlin et al.|Urologic Oncology Seminars and Original Investigations|2012Cited by 21
Assessment of time from cytoreductive nephrectomy (CN) to initiation of targeted therapy (TT) in patients with metastatic renal cell carcinoma (mRCC).Winston Vuong, Sumanta Kumar Pal, Mark Chang et al.|Journal of Clinical Oncology|2014Cited by 0